mk-2206 and oridonin

mk-2206 has been researched along with oridonin* in 1 studies

Other Studies

1 other study(ies) available for mk-2206 and oridonin

Article	Year
Targeting AKT with Oridonin Inhibits Growth of Esophageal Squamous Cell Carcinoma Molecular cancer therapeutics, 2018, Volume: 17, Issue:7 Overexpression or activation of AKT is very well known to control cell growth, survival, and gene expression in solid tumors. Oridonin, an inflammatory medical and diterpenoid compound isolated from Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Diterpenes, Kaurane; Esophageal Squamous Cell Carcinoma; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds, 3-Ring; Humans; Isodon; Mice; Oncogene Protein v-akt; Plant Extracts; Signal Transduction; Xenograft Model Antitumor Assays	2018

Article

Year

Targeting AKT with Oridonin Inhibits Growth of Esophageal Squamous Cell Carcinoma

Molecular cancer therapeutics, 2018, Volume: 17, Issue:7

Overexpression or activation of AKT is very well known to control cell growth, survival, and gene expression in solid tumors. Oridonin, an inflammatory medical and diterpenoid compound isolated from

Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Diterpenes, Kaurane; Esophageal Squamous Cell Carcinoma; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds, 3-Ring; Humans; Isodon; Mice; Oncogene Protein v-akt; Plant Extracts; Signal Transduction; Xenograft Model Antitumor Assays

2018